Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa

Background: The SelfCerv Self-Collection Cervical Health Screening Kit (Ilex Medical Ltd., Johannesburg, South Africa) is an applicator tampon designed for self-collection of vaginal samples for the detection of human papillomavirus (HPV) deoxyribonucleic acid (DNA) and E6/E7 messenger ribonucleic a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Teboho Amelia Tiiti, Tebogo Loraine Mashishi, Varsetile Varster Nkwinika, Kgotlaethata Aaron Molefi, Ina Benoy, Johannes Bogers, Selokela Gloria Selabe, Ramokone Lisbeth Lebelo
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	South Africa SelfCerv HPV cervical cancer self-sampling E6/E7 mRNA Medicine R
Acceso en línea:	https://doaj.org/article/4ebf7f6868f04990b141a183e050a92a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4ebf7f6868f04990b141a183e050a92a
record_format	dspace
spelling	oai:doaj.org-article:4ebf7f6868f04990b141a183e050a92a2021-11-11T17:29:23ZEvaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa10.3390/jcm102148172077-0383https://doaj.org/article/4ebf7f6868f04990b141a183e050a92a2021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/4817https://doaj.org/toc/2077-0383Background: The SelfCerv Self-Collection Cervical Health Screening Kit (Ilex Medical Ltd., Johannesburg, South Africa) is an applicator tampon designed for self-collection of vaginal samples for the detection of human papillomavirus (HPV) deoxyribonucleic acid (DNA) and E6/E7 messenger ribonucleic acid (mRNA). The study aimed to evaluate the performance of the SelfCerv applicator tampon for the detection of hr-HPV for cervical cancer screening, and further to investigate women’s experiences and preferences regarding self-sampling. Methods: Vaginal samples were collected from 527 gynecology clinic attendees aged ≥18 years at a tertiary hospital in Gauteng Province, South Africa. Self-samples were collected using the SelfCerv kit, followed by endocervical samples collected by a healthcare professional using Cervex-Brush<sup>®</sup> Combi. Participants completed a self-administered questionnaire on self-sampling experiences and preferences. Both samples were tested for 14 high-risk (hr) HPV types and E6/E7 mRNA using the Abbott RealTime HR-HPV and Aptima HR-HPV mRNA assays, respectively. Results: The overall agreement for hr-HPV typing between 527 paired samples was good (87.1%; κ =0.74) with high sensitivity (86.2%) and specificity (88.0%). HPV-16 (96.4%; κ = 0.83) had higher agreement rate than HPV-18 (96.8%; κ = 0.72) and the other 12 hr-HPVs (86.5%; κ = 0.72). Two hundred and eighty-five (285) sample pairs tested for E6/E7 mRNA showed fair agreement (70.2%; κ= 0.34). Furthermore, self-sampling was reported as comfortable (90.5%) and painless (86.7%), with 88.4% of women preferring self-collection. Conclusions: Self-collected samples had good agreement with the healthcare professional-collected samples for the detection of hr-HPV DNA and the procedure was highly preferred by women. Self-sampling using SelfCerv can be used as an alternative to healthcare professional sampling in clinic-based routine cervical cancer screening.Teboho Amelia TiitiTebogo Loraine MashishiVarsetile Varster NkwinikaKgotlaethata Aaron MolefiIna BenoyJohannes BogersSelokela Gloria SelabeRamokone Lisbeth LebeloMDPI AGarticleSouth AfricaSelfCervHPVcervical cancerself-samplingE6/E7 mRNAMedicineRENJournal of Clinical Medicine, Vol 10, Iss 4817, p 4817 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	South Africa SelfCerv HPV cervical cancer self-sampling E6/E7 mRNA Medicine R
spellingShingle	South Africa SelfCerv HPV cervical cancer self-sampling E6/E7 mRNA Medicine R Teboho Amelia Tiiti Tebogo Loraine Mashishi Varsetile Varster Nkwinika Kgotlaethata Aaron Molefi Ina Benoy Johannes Bogers Selokela Gloria Selabe Ramokone Lisbeth Lebelo Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
description	Background: The SelfCerv Self-Collection Cervical Health Screening Kit (Ilex Medical Ltd., Johannesburg, South Africa) is an applicator tampon designed for self-collection of vaginal samples for the detection of human papillomavirus (HPV) deoxyribonucleic acid (DNA) and E6/E7 messenger ribonucleic acid (mRNA). The study aimed to evaluate the performance of the SelfCerv applicator tampon for the detection of hr-HPV for cervical cancer screening, and further to investigate women’s experiences and preferences regarding self-sampling. Methods: Vaginal samples were collected from 527 gynecology clinic attendees aged ≥18 years at a tertiary hospital in Gauteng Province, South Africa. Self-samples were collected using the SelfCerv kit, followed by endocervical samples collected by a healthcare professional using Cervex-Brush<sup>®</sup> Combi. Participants completed a self-administered questionnaire on self-sampling experiences and preferences. Both samples were tested for 14 high-risk (hr) HPV types and E6/E7 mRNA using the Abbott RealTime HR-HPV and Aptima HR-HPV mRNA assays, respectively. Results: The overall agreement for hr-HPV typing between 527 paired samples was good (87.1%; κ =0.74) with high sensitivity (86.2%) and specificity (88.0%). HPV-16 (96.4%; κ = 0.83) had higher agreement rate than HPV-18 (96.8%; κ = 0.72) and the other 12 hr-HPVs (86.5%; κ = 0.72). Two hundred and eighty-five (285) sample pairs tested for E6/E7 mRNA showed fair agreement (70.2%; κ= 0.34). Furthermore, self-sampling was reported as comfortable (90.5%) and painless (86.7%), with 88.4% of women preferring self-collection. Conclusions: Self-collected samples had good agreement with the healthcare professional-collected samples for the detection of hr-HPV DNA and the procedure was highly preferred by women. Self-sampling using SelfCerv can be used as an alternative to healthcare professional sampling in clinic-based routine cervical cancer screening.
format	article
author	Teboho Amelia Tiiti Tebogo Loraine Mashishi Varsetile Varster Nkwinika Kgotlaethata Aaron Molefi Ina Benoy Johannes Bogers Selokela Gloria Selabe Ramokone Lisbeth Lebelo
author_facet	Teboho Amelia Tiiti Tebogo Loraine Mashishi Varsetile Varster Nkwinika Kgotlaethata Aaron Molefi Ina Benoy Johannes Bogers Selokela Gloria Selabe Ramokone Lisbeth Lebelo
author_sort	Teboho Amelia Tiiti
title	Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
title_short	Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
title_full	Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
title_fullStr	Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
title_full_unstemmed	Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
title_sort	evaluation of ilex selfcerv for detection of high-risk human papillomavirus infection in gynecology clinic attendees at a tertiary hospital in south africa
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/4ebf7f6868f04990b141a183e050a92a
work_keys_str_mv	AT tebohoameliatiiti evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica AT tebogolorainemashishi evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica AT varsetilevarsternkwinika evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica AT kgotlaethataaaronmolefi evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica AT inabenoy evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica AT johannesbogers evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica AT selokelagloriaselabe evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica AT ramokonelisbethlebelo evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica
_version_	1718432061666099200

Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa

Ejemplares similares